| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
JB Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM)
JBCHEPHARM Technical Analysis
2
| As on 19th Apr 2024 JBCHEPHARM SHARE Price closed @ 1779.60 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1891.83 & Strong Buy for SHORT-TERM with Stoploss of 1659.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
JBCHEPHARMSHARE Price
| Open | 1795.00 | Change | Price | % |
| High | 1798.00 | 1 Day | -18.20 | -1.01 |
| Low | 1770.35 | 1 Week | -20.20 | -1.12 |
| Close | 1779.60 | 1 Month | 194.70 | 12.28 |
| Volume | 202911 | 1 Year | -349.35 | -16.41 |
| 52 Week High 2921.00 | 52 Week Low 1438.65 | ||||
NSE INDIA Most Active Stocks
| IDEA | 12.90 | -2.27% |
| YESBANK | 23.95 | 0.21% |
| GTLINFRA | 1.75 | 0.00% |
| NHPC | 87.15 | -2.63% |
| TATASTEEL | 162.10 | 1.28% |
| SUZLON | 39.35 | -4.37% |
| INDUSTOWER | 351.40 | 2.03% |
| PNB | 128.25 | -1.00% |
| SAIL | 146.05 | 0.86% |
| ZOMATO | 189.20 | 2.16% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| EXCEL | 0.50 | -9.09% |
| ANMOL | 42.25 | -7.85% |
| SHARDAMOTR | 1504.15 | -5.41% |
| TATACOMM | 1755.20 | -5.33% |
| JUBLPHARMA | 665.00 | -5.09% |
| ARENTERP | 52.10 | -5.01% |
| PVP | 31.30 | -5.01% |
| PVP | 31.30 | -5.01% |
| ARVEE | 237.35 | -5.00% |
| GKWLIMITED | 2531.05 | -5.00% |
| JBCHEPHARM Daily Charts |
JBCHEPHARM Intraday Charts |
Whats New @ Bazaartrend |
JBCHEPHARM Free Analysis |
|
|
JBCHEPHARM Important Levels Intraday
| RESISTANCE | 1832.88 |
| RESISTANCE | 1815.79 |
| RESISTANCE | 1805.23 |
| RESISTANCE | 1794.67 |
| SUPPORT | 1764.53 |
| SUPPORT | 1753.97 |
| SUPPORT | 1743.41 |
| SUPPORT | 1726.32 |
JBCHEPHARM Target April 2024
| 4th UP Target | 2417.82 |
| 3rd UP Target | 2133.54 |
| 2nd UP Target | 1957.82 |
| 1st UP Target | 1782.1 |
| 1st DOWN Target | 1280.7 |
| 2nd DOWN Target | 1104.98 |
| 3rd DOWN Target | 929.26 |
| 4th DOWN Target | 644.98 |
JBCHEPHARM Weekly Target
| 4th UP Target | 2090.68 |
| 3rd UP Target | 1997.39 |
| 2nd UP Target | 1939.73 |
| 1st UP Target | 1882.07 |
| 1st DOWN Target | 1717.53 |
| 2nd DOWN Target | 1659.87 |
| 3rd DOWN Target | 1602.21 |
| 4th DOWN Target | 1508.92 |
JBCHEPHARM Target2024
| 4th UP Target | 5102.02 |
| 3rd UP Target | 3986.81 |
| 2nd UP Target | 3297.47 |
| 1st UP Target | 2608.13 |
| 1st DOWN Target | 641.17 |
| 2nd DOWN Target | -48.17 |
| 3rd DOWN Target | -737.51 |
| 4th DOWN Target | -1852.72 |
JB Chemicals & Pharmaceuticals Limited ( NSE INDIA Symbol : JBCHEPHARM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
JBCHEPHARM Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 43.98 | Sideways | |
| MFI (14) | MFI is 58.29 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -47.64 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 573.64 | |
| 10 Day Avg Volume | Traded -30.03 % Less then 10 Day Average Volume | ||
JBCHEPHARM Other Details
| Segment | EQ | |
| Market Capital | 129365377024.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
JBCHEPHARM Address
 |
||
JBCHEPHARM Latest News
JBCHEPHARM Business Profile
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. The company manufactures a range of specialty products that include various pharmaceutical dosage forms. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and medicated and herbal lozenges. The company was incorporated in 1976 and is headquartered in Mumbai, India. Address: Cnergy IT Park, Mumbai, India, 400025
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service